127 related articles for article (PubMed ID: 25443276)
1. CDK1 and CDK2 activity is a strong predictor of renal cell carcinoma recurrence.
Hongo F; Takaha N; Oishi M; Ueda T; Nakamura T; Naitoh Y; Naya Y; Kamoi K; Okihara K; Matsushima T; Nakayama S; Ishihara H; Sakai T; Miki T
Urol Oncol; 2014 Nov; 32(8):1240-6. PubMed ID: 25443276
[TBL] [Abstract][Full Text] [Related]
2. Determination of the specific activity of CDK1 and CDK2 as a novel prognostic indicator for early breast cancer.
Kim SJ; Nakayama S; Miyoshi Y; Taguchi T; Tamaki Y; Matsushima T; Torikoshi Y; Tanaka S; Yoshida T; Ishihara H; Noguchi S
Ann Oncol; 2008 Jan; 19(1):68-72. PubMed ID: 17956886
[TBL] [Abstract][Full Text] [Related]
3. The cell cycle profiling-risk score based on CDK1 and 2 predicts early recurrence in node-negative, hormone receptor-positive breast cancer treated with endocrine therapy.
Kim SJ; Masuda N; Tsukamoto F; Inaji H; Akiyama F; Sonoo H; Kurebayashi J; Yoshidome K; Tsujimoto M; Takei H; Masuda S; Nakamura S; Noguchi S
Cancer Lett; 2014 Dec; 355(2):217-23. PubMed ID: 25218592
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS
Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453
[TBL] [Abstract][Full Text] [Related]
5. Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer.
Zeestraten EC; Maak M; Shibayama M; Schuster T; Nitsche U; Matsushima T; Nakayama S; Gohda K; Friess H; van de Velde CJ; Ishihara H; Rosenberg R; Kuppen PJ; Janssen KP
Br J Cancer; 2012 Jan; 106(1):133-40. PubMed ID: 22108518
[TBL] [Abstract][Full Text] [Related]
6. Prognostic evaluation of COX-2 expression in renal cell carcinoma.
Kankuri-Tammilehto MK; Söderström KO; Pelliniemi TT; Vahlberg T; Pyrhönen SO; Salminen EK
Anticancer Res; 2010 Jul; 30(7):3023-30. PubMed ID: 20683050
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of two lipid metabolism enzymes, HADHA and ACAT2, in clear cell renal cell carcinoma.
Zhao Z; Lu J; Han L; Wang X; Man Q; Liu S
Tumour Biol; 2016 Jun; 37(6):8121-30. PubMed ID: 26715271
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma.
Leibovich BC; Sheinin Y; Lohse CM; Thompson RH; Cheville JC; Zavada J; Kwon ED
J Clin Oncol; 2007 Oct; 25(30):4757-64. PubMed ID: 17947723
[TBL] [Abstract][Full Text] [Related]
9. p21-activated kinase 1 predicts recurrence and survival in patients with non-metastatic clear cell renal cell carcinoma.
Zhu Y; Xu L; An H; Liu W; Wang Z; Xu J
Int J Urol; 2015 May; 22(5):447-53. PubMed ID: 25711487
[TBL] [Abstract][Full Text] [Related]
10. A novel marker ADAM17 for clear cell renal cell carcinomas: implication for patients' prognosis.
Li G; Forest F; Feng G; Gentil-Perret A; Péoc'h M; Cottier M; Mottet N
Urol Oncol; 2014 Nov; 32(8):1272-6. PubMed ID: 24996774
[TBL] [Abstract][Full Text] [Related]
11. Activated extracellular signal-regulated kinase is an independent prognostic factor in clinically confined renal cell carcinoma.
Campbell L; Nuttall R; Griffiths D; Gumbleton M
Cancer; 2009 Aug; 115(15):3457-67. PubMed ID: 19526593
[TBL] [Abstract][Full Text] [Related]
12. Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma.
Cornejo KM; Lu M; Yang P; Wu S; Cai C; Zhong WD; Olumi A; Young RH; Wu CL
Hum Pathol; 2015 Jun; 46(6):820-6. PubMed ID: 25827535
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
[TBL] [Abstract][Full Text] [Related]
14. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery.
Ishimura T; Sakai I; Hara I; Eto H; Miyake H
Int J Urol; 2004 May; 11(5):264-8. PubMed ID: 15147540
[TBL] [Abstract][Full Text] [Related]
15. Late recurrence of renal cell carcinoma >5 years after surgery: clinicopathological characteristics and prognosis.
Park YH; Baik KD; Lee YJ; Ku JH; Kim HH; Kwak C
BJU Int; 2012 Dec; 110(11 Pt B):E553-8. PubMed ID: 22578274
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays.
Zimpfer A; Maruschke M; Rehn S; Kundt G; Litzenberger A; Dammert F; Zettl H; Stephan C; Hakenberg OW; Erbersdobler A
BJU Int; 2014 Aug; 114(2):296-302. PubMed ID: 24215118
[TBL] [Abstract][Full Text] [Related]
17. Expression of molecular markers associated with the mammalian target of rapamycin pathway in nonmetastatic renal cell carcinoma: Effect on prognostic outcomes following radical nephrectomy.
Nishikawa M; Miyake H; Harada K; Fujisawa M
Urol Oncol; 2014 Jan; 32(1):49.e15-21. PubMed ID: 24239474
[TBL] [Abstract][Full Text] [Related]
18. Cyclin-Dependent Kinase Activity Correlates with the Prognosis of Patients Who Have Gastrointestinal Stromal Tumors.
Nishida T; Matsushima T; Tsujimoto M; Takahashi T; Kawasaki Y; Nakayama S; Omori T; Yamamura M; Cho H; Hirota S; Ueshima S; Ishihara H
Ann Surg Oncol; 2015 Oct; 22(11):3565-73. PubMed ID: 25707496
[TBL] [Abstract][Full Text] [Related]
19. Vascular cell adhesion molecule 1 predicts cancer-free survival in clear cell renal carcinoma patients.
Shioi K; Komiya A; Hattori K; Huang Y; Sano F; Murakami T; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
Clin Cancer Res; 2006 Dec; 12(24):7339-46. PubMed ID: 17189405
[TBL] [Abstract][Full Text] [Related]
20. Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer.
Li G; Feng G; Gentil-Perret A; Genin C; Tostain J
J Urol; 2008 Aug; 180(2):510-3; discussion 513-4. PubMed ID: 18550116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
